Lyra Therapeutics (LYRA) Q1 2026 Earnings

Mar 31Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-7.5
-5.86
-4.23
-2.59

Details

Expected EPS
-2.59
Actual EPS
-7.14
Surprise EPS
-4.55
Surprise Percent
-175.68%

Description

⁨Lyra Therapeutics⁩ (⁦LYRA⁩) has reported earnings of ⁦-7.14⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts